These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 1626492

  • 1. Review of randomized trials of digoxin therapy in patients with chronic heart failure.
    Gheorghiade M, Zarowitz BJ.
    Am J Cardiol; 1992 Jun 04; 69(18):48G-62G; discussion 62G-63G. PubMed ID: 1626492
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm.
    Kromer EP, Elsner D, Riegger GA.
    J Cardiovasc Pharmacol; 1990 Jul 04; 16(1):9-14. PubMed ID: 1696671
    [Abstract] [Full Text] [Related]

  • 5. [Digoxin and angiotensin-converting enzyme inhibitors in the treatment of chronic congestive heart failure].
    Thery C.
    Therapie; 1994 Jul 04; 49(3):211-8. PubMed ID: 7878586
    [Abstract] [Full Text] [Related]

  • 6. Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.
    Gambassi G, Lapane KL, Sgadari A, Carbonin P, Gatsonis C, Lipsitz LA, Mor V, Bernabei R.
    Arch Intern Med; 2000 Jan 10; 160(1):53-60. PubMed ID: 10632305
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE, Ziesche S, Carson PE, Conrad CH, Syat D, Cohn JN.
    Am J Cardiol; 1996 May 15; 77(12):1078-82. PubMed ID: 8644661
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. From digoxin to angiotensin-converting enzyme inhibitors: issues in pharmacotherapy for congestive heart failure.
    Hackenbruck HA.
    Clin Excell Nurse Pract; 2000 Jul 15; 4(4):197-204. PubMed ID: 11261079
    [Abstract] [Full Text] [Related]

  • 19. Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme.
    Young JB, Gheorghiade M, Uretsky BF, Patterson JH, Adams KF.
    J Am Coll Cardiol; 1998 Sep 15; 32(3):686-92. PubMed ID: 9741512
    [Abstract] [Full Text] [Related]

  • 20. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K.
    Am J Cardiovasc Drugs; 2002 Sep 15; 2(1):1-6. PubMed ID: 14727993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.